TY - JOUR KW - Animals KW - Antibodies, Bacterial KW - Antigens, Bacterial KW - Armadillos KW - Bacteriological Techniques KW - Disease Models, Animal KW - Early Diagnosis KW - Humans KW - Immunoassay KW - leprosy KW - Mycobacterium leprae AU - Duthie M AU - Truman RW AU - Goto W AU - O'Donnell J AU - Hay MN AU - Spencer JS AU - Carter D AU - Reed S AB -

Leprosy is a debilitating chronic disease caused by infection with Mycobacterium leprae. A World Health Organization-directed control strategy based upon the identification and treatment of patients has resulted in a marked reduction in the number of registered worldwide leprosy cases over the last 20 years. Despite these efforts, the number of new leprosy cases detected each year now remains relatively stable, and M. leprae infection continues to pose a health problem. It is suggested that earlier diagnosis is required to strengthen control programs. In this study, we have examined the development of antigen-specific immunoglobulin responses within armadillos experimentally infected with M. leprae to identify those responses that develop most rapidly and robustly following infection. Antibody responses to the M. leprae-specific phenolic glycolipid I and several protein antigens previously demonstrated to have diagnostic potential were assessed. Our results identify several antigens that can provide early diagnosis of M. leprae infection but also indicate considerable variability in the development of antigen-specific antibodies. Our data suggest that a combination of antigens is likely required to provide accurate and early leprosy diagnosis.

BT - Clinical and vaccine immunology : CVI C1 - http://www.ncbi.nlm.nih.gov/pubmed/21177914?dopt=Abstract CN - DUTHIE2011a DA - 2011 Feb DO - 10.1128/CVI.00420-10 IS - 2 J2 - Clin. Vaccine Immunol. LA - eng N2 -

Leprosy is a debilitating chronic disease caused by infection with Mycobacterium leprae. A World Health Organization-directed control strategy based upon the identification and treatment of patients has resulted in a marked reduction in the number of registered worldwide leprosy cases over the last 20 years. Despite these efforts, the number of new leprosy cases detected each year now remains relatively stable, and M. leprae infection continues to pose a health problem. It is suggested that earlier diagnosis is required to strengthen control programs. In this study, we have examined the development of antigen-specific immunoglobulin responses within armadillos experimentally infected with M. leprae to identify those responses that develop most rapidly and robustly following infection. Antibody responses to the M. leprae-specific phenolic glycolipid I and several protein antigens previously demonstrated to have diagnostic potential were assessed. Our results identify several antigens that can provide early diagnosis of M. leprae infection but also indicate considerable variability in the development of antigen-specific antibodies. Our data suggest that a combination of antigens is likely required to provide accurate and early leprosy diagnosis.

PY - 2011 SP - 254 EP - 9 T2 - Clinical and vaccine immunology : CVI TI - Insight toward early diagnosis of leprosy through analysis of the developing antibody responses of Mycobacterium leprae-infected armadillos. UR - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3067361/pdf/0420-10.pdf VL - 18 SN - 1556-679X ER -